travel grant esmo

Sign up to the newsletter

Travel grant: esmo breast, 15-17 may 2024, berlin, germany.

Full applications should be submitted to [email protected] by 9 February 2024 providing the following documents: - Short curriculum vitae - Letter describing the motivation for attending - Application form

Catalyzing Change: Young Moroccan Oncologists Spearhead the Fight Against Sarcoma

The management of sarcoma presents several challenges because of its rarity and diverse subtypes, making accurate diagnosis and specialized treatment crucial. A multidisciplinary approach involving various experts from different cancer specialties is the optimal strategy to improve survival and reduce recurrence rates. Limited awareness and expertise in sarcoma among health-care professionals may lead to delayed or suboptimal management, emphasizing the importance of specialized sarcoma centers, particularly in low- and middle-income countries.

Research efforts are ongoing to develop targeted therapies and improve treatment outcomes, but more research and clinical trials are needed given the rarity and heterogeneity of sarcomas. This year, the European Society for Medical Oncology (ESMO) organized the inaugural ESMO Sarcoma and Rare Cancers Congress, which took place from March 20 to 22, 2023, in Lugano, Switzerland. This highly specialized meeting integrated the content of the former ESMO Sarcoma and GIST Symposium and the updated ESO-ESMO-RCE (European School of Oncology–ESMO–Rare Cancers Europe) Clinical Day on Sarcomas and Rare Adult Solid Cancers, bringing together esteemed international experts and the brightest minds working in these areas of cancer research. This event provided a unique opportunity for the international rare cancer community to foster new collaborations and engage in discussions on challenging cases with renowned experts in this field, including Jean-Yves Blay, MD, PhD; Judith Bovée, MD, PhD; and Robin L. Jones, PhD; among others.

travel grant esmo

Meeting Highlights

This event provided insights into the diagnosis, prognosis, management, and research outputs of rare adult solid cancers. Specifically, after the inaugural session, the morning was devoted to an overview of the molecular classification, biology, diagnosis, and management of ultra-rare sarcomas, as well as rare cancers of the gynecologic and genitourinary tracts, along with other rare skin cancers. The afternoon was dedicated to sessions discussing advances and challenges in the surgical management of sarcomas (including extremely rare types of thoracic and head/neck cancers).

Additionally, topics included the management of neuroendocrine tumors and how artificial intelligence (AI) may be integrated into this field of rare cancers. AI holds great promise in managing rare cancers by providing performant algorithms to analyze medical images to aid in the early detection and accurate diagnosis of rare cancers. Furthermore, AI can scrutinize genomic and molecular data to identify specific biomarkers and potential therapeutic targets, and this may assist clinicians in tailoring treatment approaches and selecting the most effective therapies for patients.

Focus on Young Oncologists

On the second day of the congress, educational and scientific sessions covered state-of-the-art multidisciplinary care for patients affected by rare solid tumors, as defined by the European Reference Networks. In addition, precision therapies for rare cancers and specific rare molecular subgroups of common cancers were addressed. This meeting dedicated several sessions to discussing methodologic, policy, and advocacy issues focused on rare cancers. A Young Oncologist session provided young oncologists from around the world with an opportunity to exchange ideas, share experiences, and discuss the challenges they face in treating rare sarcomas and cancers within their respective settings. The aim was to foster collaborations and develop perspective solutions.

Moreover, the congress served as a remarkable platform for young oncologists to present their original scientific research advancements through oral and poster communications. (See the photo of Dr. Saoussane Kharmoum presenting her poster after receiving a merit travel grant from ESMO to attend the conference.) Indeed, four oral communications were presented, followed by discussions led by experts in the field. The presentations focused on the tumor of the sex cord of the ovaries, adenocarcinoma of the appendix, and neuroendocrine tumors.

A poster session was also scheduled where each author presented his or her study findings to the ESMO committee and the participants. This session generated a lot of discussion and exchange between presenters and attendees. It is worth noting that some presenters received ESMO merit grants to cover their accommodation and travel expenses, enabling young oncologists from around the world to attend and showcase their research work.

Jinane Kharmoum, MD

Jinane Kharmoum, MD

Mariame Chraibi, MD

Mariame Chraibi, MD

Mohammed Shimi, MD

Mohammed Shimi, MD

Hassan Errihani, MD, PhD

Hassan Errihani, MD, PhD

Survey-Based Sarcoma Study Findings From Morocco

Our communicated abstract summarized a cross-sectional survey-based study conducted in Morocco. The study aimed to investigate the challenges faced by Moroccan practitioners in managing extremity sarcomas. We surveyed 153 medical oncologists, radiation oncologists, and orthopedic traumatologists and found that oncologists often received sarcoma cases without prior biopsy or imaging assessment. Additionally, a significant proportion of surgeons lacked specialization in surgical oncology. Limited access to imaging and specialized pathology services was observed, and participation in sarcoma multidisciplinary meetings was low. The majority of practitioners reported difficulties in determining the best therapeutic options for patients. Furthermore, high-dose methotrexate-based protocols were not used in adult cancer centers, and there were challenges in accessing rehabilitation, physiotherapy, and psychotherapeutic management services. Our study highlights the challenges Morocco faces in accurately diagnosing and treating sarcomas, emphasizing the urgent need for a national reference sarcoma center with expert multidisciplinary teams.

A Valuable Opportunity

The opportunity to attend an ESMO scientific event is highly anticipated by young oncologists from around the globe, especially those practicing in low- and mid dle-income countries such as Morocco. It provides us with a valuable opportunity to engage in real-time interactions with esteemed experts in the field of sarcoma and benefit from their exten sive experience in large-scale clinical trials and real-world evidence.

In our setting in Morocco, the field of sarcoma oncology is not well developed, and we have received insufficient training in managing these rare cancers. Therefore, there is an urgent need for qualified human resources in sarcoma oncology, particularly in resource-limited settings. The involvement of international oncology societies such as ESMO remains one of the best approaches to support health-care professionals and advance their careers in oncology.

Closing Thoughts From Dr. Saoussane Kharmoum

As a passionate young Moroccan medical oncologist dedicated to the management of sarcomas and eager to advance research and enhance patient care in my country, this event presented a golden opportunity for me. It allowed me to explore groundbreaking data with the potential to transform practices in this field, such as precision medicine. Furthermore, I gained new insights into the biology, molecular classification, and diagnosis of sarcomas and rare cancers. The event facilitated the exchange of promising ideas with like-minded oncologists who share similar concerns. Additionally, I had the chance to present my own research on the challenges faced in the management of sarcomas in Morocco, thereby amplifying the voices of my patients on an international stage . 

Dr. Saoussane Kharmoum is a medical oncologist at Regional Hospital Center, Tangier, Morocco. Dr. Jinane Kharmoum is Assistant Professor, Laboratory of Pathology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Tangier, Abdelmalek Essaâdi University, Tétouan. Dr. Chraibi is Professor and Head of the Laboratory of Pathology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Tangier, Abdelmalek Essaâdi University, Tétouan. Dr. Shimi is Professor and Head of the Department of Trauma and Orthopaedics, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Tangier, Abdelmalek Essaâdi University, Tétouan. Dr. Errihani is Professor and Head of the Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.

DISCLOSURE: Dr. Saoussane Kharmoum has participated in a speakers bureau for MSD Oncology and Roche; and has been reimbursed for travel expenses by AstraZeneca and Merck. Dr. Jinane Kharmoum , Dr. Chraibi , and Dr. Shimi reported no conflicts of interest. Dr. Errihani has served as a consultant or advisor for MSD; has participated in a speakers bureau for Novartis, and AstraZeneca; and has received research funding from Roche.

SUGGESTED READINGS

1. Kharmoum S, Najdi A, Kharmoum J, et al: 91P Management challenges of extremity sarcomas in under-resourced settings: The first survey-based study in Morocco. ESMO Open 8(suppl 3):101128, 2023.

2. Kharmoum J, Serhrouchni KI, Eliahai I, et al: Exploring real-world practices and challenges of sarcoma diagnosis in Morocco: A survey-based study among 144 pathologists. Acta Biomed 94:e2023006, 2023.

3. ESMO Daily Reporter: Access to high-quality care for sarcomas is still unequal worldwide. March 20, 2023. Available at https://dailyreporter.esmo.org/esmo-sarcoma-and-rare-cancers-congress-2023/esmo-sarcoma-and-rare-cancers-congress-2023/access-to-high-quality-care-for-sarcomas-is-still-unequal-worldwide. Accessed August 28, 2023.

Advanced Melanoma Efficacy of Monoclonal Antibody Doublet

Endometrial thickness in triage for endometrial cancer among black women, novel algorithm may help to identify aggressive basal cell carcinoma, exploring health-care provider attitudes toward hpv self-collection testing, exercise may prevent nerve damage during chemotherapy.

Conexiant Oncology Logo

  • Editorial Board
  • Advertising
  • Disclosures
  • Privacy Policy

Weill Cornell Medicine

  • Weill Cornell Medicine

Pathology & Laboratory Medicine

Dr. Nuzzo wins Best Poster Award at ESMO Targeted Anticancer Therapies Congress 2024

  • Share to Facebook
  • Share to Twitter
  • Share to LinkedIn
  • Share on Email

Dr. Pier Nuzzo

Dr. Pier Vitale Nuzzo has been recognized for their outstanding work at the recent ESMO Targeted Anticancer Therapies Congress (TAT) 2024 in Paris (26-28 February 2024).

Dr. Nuzzo received two prestigious awards - the ESMO Merit Travel Grant and the ESMO TAT Award for Best Poster - with the abstract " Targeting de novo lipogenesis synergizes with androgen receptor inhibitors in castration-resistant prostate cancer ". 

Out of over 120 presentations, the ESMO TAT scientific committee acknowledged Dr. Nuzzo's work for the promising preliminary data and innovative design of a phase I clinical trial with the new Fatty acid synthase (FASN) inhibitor combined with Enzalutamide for the treatment of metastatic castration-resistant prostate cancer (mCRPC). 

The trial is currently underway at Weill Cornell Medicine (WCM) and is actively recruiting patients ( NCT05743621 ).

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Surgical Pathology: (212) 746-2700

OncoDaily News

Elisa Agostinetto,  Research Fellow at  Jules Bordet Institute in Brussels, shared a post on X/Twitter:

“Happy to receive a ESMO – Eur. Oncology Merit Travel Grant for the work we will present at the upcoming ESMO Breast24 ! See you all in Berlin .”

travel grant esmo

Source: Elisa Agostinetto/X

travel grant esmo

Treatment Resistance Group

UCL Cancer Institute, London, UK

Agilent Thought Leader Award, Gert Attard

Early Career Entrepreneur of the Year CRUK Cancer Horizons , Anjui Wu

European Society of Medical Oncology (ESMO) Translational Fellowship , 2022-2024, Nicole Brighi

Jean Shanks and Pathological Society Clinical PhD Fellowship , Charles Parker

Medical Research Council (MRC) Clinical Research  Training  Fellowship,  Gianmarco Leone

Prostate Cancer Foundation Young Investigator Award (YIA) , Emily Grist

Conquer Cancer Foundation ASCO Merit Award , Emily Grist

Prostate Cancer Foundation Young Investigator Award (YIA) , Anu Jayaram

Conquer Cancer Foundation ASCO Merit Award , Cinzia Conteduca and Anu Jayaram

Wellcome Trust Travel Award , Anjui Wu

ESMO Travel Grant for MAP Conference , Emily Grist

ESMO Travel Grant for MAP Conference , Anu Jayaram

CfDNA Conference Travel Grant , Anjui Wu

University of London Travel Grant , Anjui Wu

Best Fellowship Award from ESMO , Cinzia Conteduca

Cancer Research UK Future Leader’s Prize , Gert Attard

Appointment to Fellow of the Royal College of Physicians , Gert Attard

Cancer Research UK (CRUK) Young Investigator Travel Award , Anjui Wu

ICR Annual Conference  Poster Prize Winner , Karolina Nowakowska

Medical Research Council (MRC) Clinical Research Fellowship , Anu Jayaram

CRUK Clinical Training Award , Emily Grist

Evolutionary Biology and Ecology of Cancer Course Bursary, Karolina Nowakowska

Androgens Meeting  Oral Presentation Prize Winner , Karolina Nowakowska

I nvitation to ECCO-AACR-EORTC-ESMO Flims Workshop on Methods in Clinical Cancer Research , Cinzia Conteduca and Anu Jayaram

European Society of Medical Oncology (ESMO) Translational Fellowship , 2014-2016, Cinzia Conteduca

Irish Health Research Board Grant , Anu Jayaram

National Institute for Health Research (NIHR) Academic Clinical Fellowship (ACF) , Emily Grist

An aerial view of University of Idaho's Moscow campus.

Virtual Tour

Experience University of Idaho with a virtual tour. Explore now

  • Discover a Career
  • Find a Major
  • Experience U of I Life

More Resources

  • Admitted Students
  • International Students

Take Action

  • Find Financial Aid
  • View Deadlines
  • Find Your Rep

Two students ride down Greek Row in the fall, amid changing leaves.

Helping to ensure U of I is a safe and engaging place for students to learn and be successful. Read about Title IX.

Get Involved

  • Clubs & Volunteer Opportunities
  • Recreation and Wellbeing
  • Student Government
  • Student Sustainability Cooperative
  • Academic Assistance
  • Safety & Security
  • Career Services
  • Health & Wellness Services
  • Register for Classes
  • Dates & Deadlines
  • Financial Aid
  • Sustainable Solutions
  • U of I Library

A mother and son stand on the practice field of the P1FCU-Kibbie Activity Center.

  • Upcoming Events

Review the events calendar.

Stay Connected

  • Vandal Family Newsletter
  • Here We Have Idaho Magazine
  • Living on Campus
  • Campus Safety
  • About Moscow

The homecoming fireworks

The largest Vandal Family reunion of the year. Check dates.

Benefits and Services

  • Vandal Voyagers Program
  • Vandal License Plate
  • Submit Class Notes
  • Make a Gift
  • View Events
  • Alumni Chapters
  • University Magazine
  • Alumni Newsletter

A student works at a computer

U of I's web-based retention and advising tool provides an efficient way to guide and support students on their road to graduation. Login to VandalStar.

Common Tools

  • Administrative Procedures Manual (APM)
  • Class Schedule
  • OIT Tech Support
  • Academic Dates & Deadlines
  • U of I Retirees Association
  • Faculty Senate
  • Staff Council

Office of Undergraduate Research

Phone: 208-885-9292

Email: [email protected]

OUR Research Grants Program

The Office of Undergraduate Research (OUR) provides financial assistance for undergraduates undertaking research projects and for students traveling to present their results at conferences.

OUR Research Semester Grants Program

The Office of Undergraduate Research (OUR) invites undergraduate students from all colleges and academic disciplines to apply for an OUR Undergraduate Research Grant. The purpose of the grant is to support the growth and development of original, independent research or creative scholarship activities during a given semester. The grant will fund materials and supplies, project-related travel expenses, etc., up to $1,000. Two funding cycles exist: one for fall semester grants and one for spring semester grants. For more information, visit Undergraduate Research Grant Guidelines (PDF)  and Undergraduate Research Grant Cover Sheet (PDF) .

Please note: Posters printed after the grant end date cannot be charged against the grant.

Application Deadline for spring Semester Awards: Nov. 1, Student will be notified by Dec. 15 Application Deadline for fall Semester Awards: April 15, Student will be notified by May 30

OUR Summer Undergraduate Research Fellowship (SURF) Program

OUR invites undergraduate students from all disciplines at University of Idaho to apply for a Summer Undergraduate Research Fellowship (SURF). The SURF Program is a 10-week summer program running June through early August that allows students to work full-time on faculty-mentored projects in any field of study. Each award includes a $5,000 student fellowship given as a stipend and $1,000 in research funds to help cover the cost of materials and supplies, project-related travel expenses, etc. For more information, view the SURF Program Application Guidelines (PDF)  and SURF Program Cover Sheet (PDF) .

Application Deadline for Summer Undergraduate Research Fellowships: Feb. 15 , Student will be notified by March 10

OUR Travel Grants

Travel Grant Applications are accepted August 1 through April 1. Travel must occur during the academic year.

OUR offers a limited number of Travel Grants (up to $800) to U of I undergraduate students to defray the cost of travel to present results of their research, scholarly or creative activities at a professional conference in their field. This grant does not fund salary or other personnel expenses.

OUR Travel Grant Requirements

Eligibility.

All currently enrolled undergraduate students who are in good academic standing are eligible to apply. The travel must occur while the student is still enrolled at U of I and the research must be conducted under the supervision of a U of I faculty research advisor. The conference to be attended must be considered a “professional conference.” Each student presenter can receive a maximum of $800 from the OUR Travel Grant program in each academic year. This grant does not fund salary or other personnel expenses. Priority will be given to students who have not previously received an OUR Travel Grant.

Application Process

Students must submit an OUR Travel Grant Application along with a letter of support from the U of I faculty advisor who mentored the student’s research project. Requests for funding must be made 45 days prior to the expected travel start date. In the detailed budget, provide your best estimate of the cost of your transportation and registration fees. Applications received by the 15th of each month will be reviewed prior to the end of the month.

Please note: Applications received in December will be reviewed with the January applicant pool.

Letter of Support

A letter of support from the U of I faculty member who mentored the student’s research project is required. The OUR seeks to support research by undergraduates at U of I mentored by faculty at U of I. The OUR cannot support student conference presentations that are based on research conducted at other universities or with a mentor who is not a U of I faculty member. This letter should include name, location and date of conference; confirmation that this is a professional conference or meeting; a brief statement confirming the faculty member’s mentorship and supervision of the student’s research; a brief statement about the student and their work; a short assessment of the potential significance of the student being invited to the conference; and whether or not this research is supported by a grant (if so, include the funder’s name). The faculty advisor statement needs to be emailed on department letterhead (PDF format) to [email protected] or delivered to the Office for Undergraduate Research.

While financial need is a consideration for selection, it is not the only criterion. We welcome applications that reflect presentations from diverse disciplines as represented in the arts and humanities, natural sciences, social sciences and the professional schools. We also encourage applications from diverse student populations such as first-time and experienced presenters.

OUR can help with the costs of transportation to the conference, hotel expenses and registration fees for the professional conference. OUR funds cannot be used to defray meal expenses. Successful applicants will be reimbursed for up to $800 of their travel, accommodation and/or meeting registration expenses. ORIGINAL receipts and a conference program will be required for reimbursement. The travel must be completed and the request for reimbursement must be made while the student is still enrolled. The request for reimbursement must be submitted within 15 days after the conference.

Additional Requirements

Recipients of OUR Travel Grants are required to present their work at the U of I Undergraduate Research Symposium, held in April. Recipients are also required to acknowledge support from the Office of Undergraduate Research on their posters or during their presentations. Please see our guidelines for acknowledging OUR support.

Download Adobe Reader

Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements:  Google Chrome 24+ ,  Mozilla Firefox 20+ ,  Internet Explorer 11 ,  Opera 15–18 ,  Apple Safari 7 ,  SeaMonkey 2.15-2.23

  • Meeting Calendar
  • OncologyPRO
  • Past Meetings
  • ESMO Gastrointestinal Cancers Congress 2024

ESMO Gastrointestinal Cancers Congress 2024: Abstracts

The abstract submission is now closed.

View the abstracts in the online programme

Abstract submission deadlines

Abstract submission categories.

  • Colon cancer
  • Rectal cancer
  • Upper digestive – Biliary, ampullary and pancreatic cancer
  • Upper digestive – Esophageal and gastric cancers
  • Hepatocellular and non-biliary liver cancer
  • Rare GI cancers (GEP-NETs, endocrine pancreatic, duodenal cancer, anal cancer, etc)
  • Miscellaneous

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings from randomised  phase II or phase III trials   with implications for clinical practice or understanding of disease processes .

The final late-breaking abstract deadline of 6 June 2024 is  under no circumstances  to be considered as an extension of the general submission deadline.

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Gastrointestinal Cancers Congress 2024.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters by end-April. Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by 10 June 2024.

Information for presenters

Detailed instructions for the preparation of slide presentations and/or posters will be made available by end-April in the section “Information for Presenters”.

Presentation and publication of accepted abstracts

The ESMO Gastrointestinal Cancers 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper  – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral  – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
  • Poster  – Display session for review, discussion and questions. The presenting authors must be available onsite for Q&A to represent their work.

All accepted abstracts will be published online only in the ESMO Gastrointestinal Cancers 2024 Abstract Book, a supplement to the official ESMO journal,  Annals of Oncology.

Publication schedule for accepted abstracts

Details regarding the publication of accepted abstracts are available  here .

ESMO Merit Travel Grants

A limited number of ESMO Merit Travel Grants to ESMO Gastrointestinal Cancers 2024 have been made available (upon application), and awarded to the following abstract presenters:

  • Margherita Ambrosini, Paris, France
  • Alessandro Audisio, Anderlecht, Belgium
  • Debora Basile, Crotone, Italy
  • Giacomo Bregni, Anderlecht, Belgium
  • Silvia Camera, Milan, Italy
  • Martina Carullo, Pisa, Italy
  • Veronica Conca, Pisa, Italy
  • Darren Cowzer, New York, NY, USA
  • Virginia Genovesi, Pisa, Italy
  • Giada Grelli, Pisa, Italy
  • Kin Nam Kwok, Hong Kong SAR, China
  • Midhun Malla, Birmingham, AL, USA
  • Valentino Martelli, Barcelona, Spain
  • Giulia Martini, Naples, Italy
  • Gianluca Mauri, Milan, Italy
  • Ronan McLaughlin, Toronto, ON, Canada
  • Gordon Moffat, Toronto, ON, Canada
  • Alberto Puccini, Rozzano, Italy
  • Federico Rossari, Milan, Italy
  • Nicolas Roussot, Dijon, France
  • Abdelrahman Yousef, Houston, TX, USA

Related Files

  • ESMO Gastrointestinal Cancers 2024 Abstract Regulations

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy .

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.

COMMENTS

  1. Travel Grants for Young Oncologists

    Throughout the year ESMO offers Merit Awards to young oncologists submitting abstracts to ESMO Meetings. The selection of Merit Award recipients is made by the Scientific Committee based on the quality of accepted abstracts. YO Travel Grants. ESMO also offer travel grants to young oncologists to attend various educational meetings.

  2. ESMO Congress 2024: Patient Travel Grant Programme

    A travel grant helps to cover travel, hotel, and registration expenses and is based primarily on an individual's financial need, as well as current advocacy activities. Each grant will reimburse travel and accommodation costs up to a maximum of 1000 EUR, and includes free registration to the ESMO Congress 2024.

  3. ESMO Congress 2023: Patient Travel Grant Programme

    ESMO is delighted to offer a limited number of travel grants to enable Patient Advocates to attend the ESMO 2023 Patient Advocacy Track in Madrid, from 20-24 October 2023. IMPORTANT: only Patient Advocates who are active ESMO members will be eligible to apply for a travel grant. Patient advocates can join ESMO for a very reasonable annual fee ...

  4. Open travel grant

    Travel grant: ESMO CongresS 2024, 13-17 September 2024, Barcelona, ES. Recipients will receive a set amount to contribute to their travel and accommodation expenses. ABC Global Alliance is not responsible for the event registration, VISA or the travel arrangements. Travel grants are made available for ABC Global Alliance members.

  5. ABC travel grants

    Travel grant: ESMO Breast, 15-17 May 2024, Berlin, Germany. Recipients will receive a set amount to contribute to their travel and accommodation expenses. ABC Global Alliance is not responsible for the event registration, VISA or the travel arrangements. The outcome of the application will be notified by 19 February 2024.

  6. We are opening a new travel grant that'll take you to #ESMO23

    We are opening a new travel grant that'll take you to #ESMO23 - ABC Global Alliance / ABCGlobalAlliance, ESMO, grant, OncoDaily, Oncology. Insight. Onco Daily. News Feed Opinion Career Insight Dialogues Blog Oncolibrary. Facebook . RSS . Twitter. Youtube . Linkedin . Positive ...

  7. ESMO 2024: Patient Advocates Travel Grant Reimbursement Policy

    Reimbursement will be processed after ESMO 2024 and one month (maximum) from receipt of details. The deadline to provide receipts is 17 October (after which date reimbursement requests will no longer be accepted). ESMO will reimburse funds to the patient association's bank account. If required, patient advocates are requested to specify their ...

  8. Catalyzing Change Young Moroccan Oncologists Spearhead the Fight

    (See the photo of Dr. Saoussane Kharmoum presenting her poster after receiving a merit travel grant from ESMO to attend the conference.) Indeed, four oral communications were presented, followed by discussions led by experts in the field. The presentations focused on the tumor of the sex cord of the ovaries, adenocarcinoma of the appendix, and ...

  9. Dr. Nuzzo wins Best Poster Award at ESMO Targeted Anticancer Therapies

    Dr. Nuzzo received two prestigious awards - the ESMO Merit Travel Grant and the ESMO TAT Award for Best Poster - with the abstract "Targeting de novo lipogenesis synergizes with androgen receptor inhibitors in castration-resistant prostate cancer ".Out of over 120 presentations, the ESMO TAT scientific committee acknowledged Dr. Nuzzo's work for the promising preliminary data and innovative ...

  10. Elisa Agostinetto: Happy to receive a ESMO Merit Travel Grant for the

    Elisa Agostinetto, Research Fellow at Jules Bordet Institute in Brussels, shared a post on X/Twitter: "Happy to receive a ESMO - Eur. Oncology Merit Travel Grant for the work we will present at the upcoming ESMO Breast24! See you all in Berlin.". Source: Elisa Agostinetto/X

  11. Reinventing ESMO after the COVID-19 pandemic: moving towards a

    Finally, ESMO travel policies for invited speakers and recipients of travel grants could specify that aeroplane travel may not be reimbursed if the travel time using train/bus/electric car is <6 hours. However, case-by-case requests will be considered. ... grant proposals and clinical trial design. ESMO can lead by example by including such ...

  12. Awards

    CfDNA Conference Travel Grant, Anjui Wu. University of London Travel Grant, Anjui Wu. Best Fellowship Award from ESMO, Cinzia Conteduca. Cancer Research UK Future Leader's Prize, Gert Attard. Appointment to Fellow of the Royal College of Physicians, Gert Attard . 2016 . Cancer Research UK (CRUK) Young Investigator Travel Award, Anjui Wu

  13. ESMO 2022: Patient Advocates (PA) Travel Grants Programme

    ESMO is delighted to offer a limited number of travel grants to enable Patient Advocates to attend the ESMO 2022 Patient Advocacy Track in Paris, from 9-13 September 2022. IMPORTANT: only Patient Advocates who are active ESMO members will be eligible to apply for a travel grant. Patient advocates can join ESMO for a very convenient annual fee ...

  14. PDF Malt Lymphoma

    • Gilead: travel grant ESMO Preceptorship on Lymphoma Lugano, 3-4 November 2017. Marginal zone B-cell lymphomas The NHL Classification Project, Blood 1997 ... ESMO guidelines: advanced stage. IELSG 19 study. IELSG 19 study Zucca et al, J Clin Oncol, 2013. Follow-up • EGILS 2011 guidelines

  15. Graduate & Professional Student Association-University of Idaho

    The Graduate & Professional Student Association (GPSA) supports and promotes graduate student education, campus sustainability and graduate student life at the University of Idaho, which includes funding awards related to professional travel, publication and workshops. This includes creating programs and assisting graduate students during their ...

  16. ESMO 2023: Patient Advocates Travel Grant Reimbursement Policy

    Travel. Patient Advocates are kindly requested to organise their own travel. ESMO will subsidise the cost of the journey to and from the Congress as follows: Flight, economy class; Fuel, 0.60 EUR / km; Taxis will be refunded for travel to and from the airport only: home- airport-home, airport-hotel-airport, airport- congress venue- airport.

  17. PDF International Geographical Union

    Moscow IGU Travel Grant Program. The International Geographical Union (IGU) announces the availability of travel grants to help defray the costs of participation in the 17 - 21 August 2015 Regional Conference in Moscow, Russia. Please note that, due to limited availability of funds, the IGU Travel Grants provide only

  18. OUR Research Grants Program

    The purpose of the grant is to support the growth and development of original, independent research or creative scholarship activities during a given semester. The grant will fund materials and supplies, project-related travel expenses, etc., up to $1,000. Two funding cycles exist: one for fall semester grants and one for spring semester grants.

  19. PDF ESMO trAvEL grAnt opportunitiEs

    ESMO CONGrESS DEParTMENT CONTaCT DETaILS The form must be duly completed and returned in its entirety: - via email to [email protected] - via fax to + 41 91 973 19 18 ESMO trAvEL grAnt opportunitiEs Events list and application process ESMO Preceptorship on Gastric Cancer 2 Geneva, Switzerland, 15 - 16 November 2013 , 20- 21December 2013

  20. ESMO Congress 2024

    The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other ...

  21. Abstracts

    All accepted abstracts will be published online only in the ESMO Gastrointestinal Cancers 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology. Publication schedule for accepted abstracts. Details regarding the publication of accepted abstracts are available here. ESMO Merit Travel Grants